Aspartic Acid

Aspartic Acid

SCHEMBL7703371

N[C@@H](CC(=O)[O-])C(=O)O.N[C@@H](CC(=O)[O-])C(=O)O.[Zn+2]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC6A2SLC6A3SSTR1SSTR2SSTR3SSTR5

The experimentally established mechanism targets of Aspartic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 9/20 0.50
GRIK2 Q13002 6/20 0.50
GRM1 Q13255 2/20 0.50
GRM2 Q14416 2/20 0.50
SLC7A5 Q01650 1/20 0.48
PTGS1 P23219 1/20 0.46
SLC7A11 Q9UPY5 1/20 0.46
GGT1 P19440 4/20 0.44
SLC1A1 P43005 4/20 0.44
GSR P00390 2/20 0.44
GRIA4 P48058 4/20 0.43
GRIK3 Q13003 4/20 0.43
GRIK5 Q16478 4/20 0.43
SLC1A3 P43003 3/20 0.43
SLC1A2 P43004 3/20 0.43
GRIA2 P42262 3/20 0.42
GRIA1 P42261 2/20 0.42
GRM8 O00222 1/20 0.42
GRM6 O15303 1/20 0.42
GRIN2D O15399 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aspartic Acid SCHEMBL9293073 1.00 GRIK1 (0.50) GRIK1GRIK2GRM1GRM2SLC7A5
Aspartic Acid SCHEMBL1301523 0.95 GRIK1 (0.50) GRIK1GRIK2GRM1GRM2SLC7A5
Aspartic Acid SCHEMBL1302394 0.95 GRIK1 (0.50) GRIK1GRIK2GRM1GRM2SLC7A5
Aspartic Acid SCHEMBL7706144 0.95 GRIK1 (0.50) GRIK1GRIK2GRM1GRM2SLC7A5
Aspartic Acid SCHEMBL1302714 0.95 GRIK1 (0.50) GRIK1GRIK2GRM1GRM2SLC7A5
Aspartic Acid SCHEMBL1259586 0.95 GRIK1 (0.50) GRIK1GRIK2GRM1GRM2SLC7A5
Aspartic Acid SCHEMBL1302396 0.95 GRIK1 (0.50) GRIK1GRIK2GRM1GRM2SLC7A5
Aspartic Acid SCHEMBL1301891 0.95 GRIK1 (0.50) GRIK1GRIK2GRM1GRM2SLC7A5
Aspartic Acid SCHEMBL1301554 0.95 GRIK1 (0.50) GRIK1GRIK2GRM1GRM2SLC7A5
Aspartic Acid SCHEMBL7700995 0.95 GRIK1 (0.50) GRIK1GRIK2GRM1GRM2SLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4418865-B1 LIQUID COMPOSITION CONTAINING A COMBINATION OF VITAMINS A, D, E AND K IN A LIQUID MATRIX LIPOID GMBH (DE) 2025-12-10 EP claimed
US-20240408113-A1 LIQUID COMPOSITION CONTAINING A COMBINATION OF VITAMINS A, D, E AND K IN A LIQUID MATRIX LIPOID GMBH (DE) 2024-12-12 US claimed
EP-4418865-A1 LIQUID COMPOSITION CONTAINING A COMBINATION OF VITAMINS A, D, E AND K IN A LIQUID MATRIX Lipoid GmbH (DE) 2024-08-28 EP claimed
WO-2023066815-A1 LIQUID COMPOSITION CONTAINING A COMBINATION OF VITAMINS A, D, E AND K IN A LIQUID MATRIX LIPOID GMBH (DE) 2023-04-27 WO claimed
EP-4169386-A1 LIQUID COMPOSITION CONTAINING A COMBINATION OF VITAMINS A, D, E AND K IN A LIQUID MATRIX Lipoid GmbH (DE) 2023-04-26 EP claimed
EP-0530220-B1 PHARMACEUTICAL COMPOSITION S & V ENGINEERING KFT (HU) 1997-09-03 EP claimed
EP-4418865-B1 LIQUID COMPOSITION CONTAINING A COMBINATION OF VITAMINS A, D, E AND K IN A LIQUID MATRIX LIPOID GMBH (DE) 2025-12-10 EP disclosed
US-20240408113-A1 LIQUID COMPOSITION CONTAINING A COMBINATION OF VITAMINS A, D, E AND K IN A LIQUID MATRIX LIPOID GMBH (DE) 2024-12-12 US disclosed
EP-4418865-A1 LIQUID COMPOSITION CONTAINING A COMBINATION OF VITAMINS A, D, E AND K IN A LIQUID MATRIX Lipoid GmbH (DE) 2024-08-28 EP disclosed
WO-2023066815-A1 LIQUID COMPOSITION CONTAINING A COMBINATION OF VITAMINS A, D, E AND K IN A LIQUID MATRIX LIPOID GMBH (DE) 2023-04-27 WO disclosed
EP-4169386-A1 LIQUID COMPOSITION CONTAINING A COMBINATION OF VITAMINS A, D, E AND K IN A LIQUID MATRIX Lipoid GmbH (DE) 2023-04-26 EP disclosed
EP-2736520-B1 COMPOSITIONS CONTAINING ZINC SALTS AND ISOTHIOCYANATES FOR REDUCTION OF ORAL VOLATILE SULFUR COMPOUNDS (VSCS) WRIGLEY W M JUN CO (US) 2020-09-09 EP disclosed
US-10543155-B2 Compositions containing zinc salts and isothiocyanates for reduction of oral volatile sulfur compounds (VSCs) WM. WRIGLEY JR. COMPANY (US) 2020-01-28 US disclosed
WO-2013015979-A2 COMPOSITIONS CONTAINING ZINC SALTS AND ISOTHIOCYANATES FOR REDUCTION OF ORAL VOLATILE SULFUR COMPOUNDS (VSCS) WM. WRIGLEY JR. COMPANY (US) 2013-01-31 WO disclosed
US-6355771-B1 MODIFIED BY MERCAPTOALKYLAMINE; CORROSION RESISTANCE, ANTISCALING AGENTS NIPPON SHOKUBAI CO., LTD. (JP) 2002-03-12 US disclosed
EP-0980883-A1 Modified polyaspartic acid, method for production thereof and use therefor Nippon Shokubai Co., Ltd. (JP) 2000-02-23 EP disclosed
EP-0530220-B1 PHARMACEUTICAL COMPOSITION S & V ENGINEERING KFT (HU) 1997-09-03 EP disclosed
US-5348749-A Adminstering mixture of zinc, magnesium, and phosphorus compounds; side effect reduction S+V ENGINEERING KFT. (HU) 1994-09-20 US disclosed
EP-0530220-A1 PHARMACEUTICAL COMPOSITION. EGAL VEGYIPARI KOEZOES VALLALA (HU) 1993-03-10 EP disclosed
WO-1991016909-A1 PHARMACEUTICAL COMPOSITION S+V ENGINEERING KFT, HUNGARY (HU) 1991-11-14 WO disclosed